References

  1. Patrice SJ, Wiss K, Mulliken Jb. Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases. Pediatr Dermatol. 1991 Dec;8(4):267-76. PubMed | Google Scholar

  2. Fortna RR, Junkins-Hopkins JM. A case of lobular capillary hemangioma (pyogenic granuloma), localized to the subcutaneous tissus and review of literature. Am J Dermatopathol. 2007 Aug;29(4):408-11. PubMed | Google Scholar

  3. Nouveau dictionnaire médical Larousse. 1987.

  4. Lin RL, Janniger CK. Pyogenic granuloma. Cutis. 2004 Oct;74(4):229-33. PubMed | Google Scholar

  5. Wauter O, Sabatiello M, Nikkels N Tassoudji, Choffray A et al. Le Botyomycome. Ann Dermatol Venereol. 2010 Mar;137(3):238-42. Google Scholar

  6. Frey J, shimeck C, Woodmansee C, Myers E, Greer S, Liman A. Aggressive digital papillary adenocarcinoma: a report of two diseases and review of the literature.. J Am Acad Dermatol. 2009 Feb;60(2):331-9. PubMed | Google Scholar

  7. Hager CM, Cohen PR. Cutaneous lesions of metatastic of visceral malignancy mimicking pyogenic granuloma. Cancer Invest. 1999;17(6):385-90. PubMed | Google Scholar

  8. Ghodsi S, Raziei R, Taheri A, Karami M, Mansoori P, Farnghi F. Comparaison of cryothérapie and curettage for the treatment of pyogenic granuloma: a randomized trial. Br J Dermatol. 2006 Apr;154(4):671-5. PubMed | Google Scholar

  9. Abregé de Pharmacologie médicale. 1982. France. Masson. PubMed | Google Scholar

  10. Revuz J. Les traitements antibiotiques dans l'hidradénite suppurée-maladie de Verneuil. Ann Dermatol Venereol. 2013 Mar;140(3):219. Google Scholar

  11. Labro MT. Interference of antibacterial agents with phagocyte functions: immunomodulatio or "immuno-fairy tales?" Clin Microbiol Rev. 2000;13:615-50. Google Scholar

  12. Altenburg J, de Graaff CS, van der Werf TS, Boersma WG. Immunomodulatory effects of macrolide antibiotics-part 1: biological mechanisms. Respiration. 2011; 81:67-74. PubMed | Google Scholar

  13. Altenburg J, de Graaff CS, van der Werf TS, Boersma WG. Immunomodulatory effects of macrolide antibiotics-part 2: advantages and disadvantages of long-term, low-dose macrolide therapy. Respiration. 2011;81(1):75-87. PubMed | Google Scholar